Showing results (1761-1770 of 14,093) with videos related to

Sort By:
Pageof 1,410
Gynecologic Oncology|August 16, 2011
It's not just for laparoscopy anymore: use of insufflation under ultrasound and fluoroscopic guidance by Interventional Radiologists for percutaneous placement of intraperitoneal chemotherapy cathetersMelissa S Henretta, Curtis L Anderson, J Fritz Angle, et al.
Gynecologic Oncology|October 11, 2011
Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancerEdward J Tanner, Destin R Black, Oliver Zivanovic, et al.
Gynecologic Oncology|October 19, 2011
20 year experience of postoperative radiotherapy in IB-IIA cervical cancer patients with intermediate risk factors: impact of treatment period and concurrent chemotherapySanghyuk Song, Changhoon Song, Hak Jae Kim, et al.
Gynecologic Oncology|October 19, 2011
Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1Chun Yang, Jing Cai, Qiyue Wang, et al.
Gynecologic Oncology|September 6, 2011
FIGO staging for carcinosarcoma: can the revised staging system predict overall survival?Tana S Pradhan, Erin E Stevens, Michael Ablavsky, et al.
Gynecologic Oncology|October 1, 2011
Defining the limits of radical cytoreductive surgery for ovarian cancerJason D Wright, Sharyn N Lewin, Israel Deutsch, et al.
Gynecologic Oncology|October 4, 2011
The importance of chemotherapy and radiation in uterine papillary serous carcinomaAkila N Viswanathan, Eric A Macklin, Ross Berkowitz, et al.
Gynecologic Oncology|August 23, 2011
Topotecan in patients with BRCA-associated and sporadic platinum-resistant ovarian, fallopian tube, and primary peritoneal cancersDavid M Hyman, Qin Zhou, Angela G Arnold, et al.
Gynecologic Oncology|August 23, 2011
A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancerClaus Høgdall, Eric T Fung, Ib J Christensen, et al.
Gynecologic Oncology|August 23, 2011
Survivors of endometrial cancer: who is at risk for sexual dysfunction?Nonyem Onujiogu, Tasha Johnson, Songwon Seo, et al.
Pageof 1,410